Tandem Diabetes Care (TNDM) Non-Current Debt (2013 - 2018)
Tandem Diabetes Care (TNDM) posted Non-Current Debt of $77.1 million for Q2 2018, up 0.91% on a QoQ basis from $76.4 million in Q1 2018, and up 3.24% year-over-year from $74.7 million in Q2 2017.
Tandem Diabetes Care (TNDM) Non-Current Debt (2013 - 2018) Analysis & Trends
Tandem Diabetes Care's Non-Current Debt history runs 6 years deep, the most recent figure standing at $77.1 million for Q2 2018.
- Quarterly Non-Current Debt rose 3.24% year-over-year to $77.1 million in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $77.1 million (up 3.24% YoY) and the FY2017 annual result came in at $76.5 million, down 3.06% from the prior year.
- Non-Current Debt was $77.1 million for Q2 2018 at Tandem Diabetes Care, up from $76.4 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $79.0 million in Q4 2016 and bottomed at $29.3 million in Q4 2015.
- A 5-year average of $50.1 million and a median of $44.3 million in 2016 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2016 — Non-Current Debt surged 169.72% — and 2017, when it declined 3.06%.
- Tandem Diabetes Care's Non-Current Debt stood at $29.4 million in 2014, then dropped by 0.56% to $29.3 million in 2015, then jumped by 169.72% to $79.0 million in 2016, then slipped by 3.06% to $76.5 million in 2017, then increased by 0.73% to $77.1 million in 2018.
- Business Quant data shows TNDM's Non-Current Debt at $77.1 million in Q2 2018, $76.4 million in Q1 2018, and $76.5 million in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 77.10 Mn |
| Mar 31, 2018 | 76.41 Mn |
| Dec 31, 2017 | 76.54 Mn |
| Sep 30, 2017 | 75.60 Mn |
| Jun 30, 2017 | 74.68 Mn |
| Mar 31, 2017 | 73.76 Mn |
| Dec 31, 2016 | 78.96 Mn |
| Sep 30, 2016 | 44.68 Mn |
| Jun 30, 2016 | 44.40 Mn |
| Mar 31, 2016 | 44.11 Mn |
| Dec 31, 2015 | 29.28 Mn |
| Sep 30, 2015 | 29.50 Mn |
| Jun 30, 2015 | 29.48 Mn |
| Mar 31, 2015 | 29.46 Mn |
| Dec 31, 2014 | 29.44 Mn |
| Sep 30, 2014 | 29.42 Mn |
| Jun 30, 2014 | 29.39 Mn |
| Mar 31, 2014 | 29.44 Mn |
| Dec 31, 2013 | 29.40 Mn |